UnitedHealth Group Incorporated (NYSE:UNH) is Eads & Heald Wealth Management’s 9th Largest Position

Eads & Heald Wealth Management cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,750 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. UnitedHealth Group comprises about 1.5% of Eads & Heald Wealth Management’s holdings, making the stock its 9th largest holding. Eads & Heald Wealth Management’s holdings in UnitedHealth Group were worth $3,027,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of UNH. Axiom Financial Strategies LLC purchased a new stake in UnitedHealth Group during the 1st quarter worth about $210,000. McGowan Group Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 8.9% in the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares during the last quarter. MAS Advisors LLC lifted its holdings in shares of UnitedHealth Group by 10.8% in the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after purchasing an additional 45 shares during the last quarter. Finally, First Western Trust Bank purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $875,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Royal Bank of Canada restated an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Oppenheimer restated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, TD Cowen dropped their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $573.80.

UnitedHealth Group Price Performance

UNH stock traded up $6.43 on Monday, reaching $445.63. The company had a trading volume of 5,352,440 shares, compared to its average volume of 4,304,973. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company’s fifty day moving average is $492.29 and its 200 day moving average is $516.34. The company has a market cap of $410.84 billion, a P/E ratio of 18.74, a PEG ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the prior year, the company earned $5.34 EPS. UnitedHealth Group’s revenue was up 14.1% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.